Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration
Clinical Pharmacology & Therapeutics · 2024-11 · 116 (5) · 1153-1155
DOI: 10.1002/cpt.3444 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 15.10.2024. Verfasst von Rebecca A Miksad. Beteiligte Einrichtung: Boston Medical Center, Boston University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Decision Making. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Boston Medical Center, Boston University, Boston, Massachusetts, USA.
- Color Health, Burlingame, California, USA.
ORCID-Profile: Rebecca A Miksad
Zitieren
APA
Miksad, R. A. (2024). Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration. Clinical Pharmacology & Therapeutics, 116(5), 1153-1155. https://doi.org/10.1002/cpt.3444
Vancouver
Miksad RA. Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration. Clinical Pharmacology & Therapeutics. 2024;116(5):1153-1155. doi:10.1002/cpt.3444
BibTeX
@article{Miksad2024,
author = {Miksad, Rebecca A},
title = {Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration},
journal = {Clinical Pharmacology & Therapeutics},
year = {2024},
volume = {116},
number = {5},
pages = {1153--1155},
doi = {10.1002/cpt.3444}
}
EUVIMED